Geographic · Total Revenues

United States — Total Revenues

Bristol-Myers Squibb United States — Total Revenues decreased by 9.0% to $7.79B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $7.87B to $7.79B. Over 4 years (FY 2021 to FY 2025), United States — Total Revenues shows an upward trend with a 3.3% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
Rolls up toTotal Revenue
Metric ID: bmy_segment_united_states_total_revenues

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$7.39B$7.30B$7.52B$7.69B$8.27B$7.94B$7.60B$7.95B$7.80B$7.54B$7.91B$8.48B$8.80B$8.23B$8.60B$7.87B$8.52B$8.33B$8.56B$7.79B
QoQ Change—-1.2%+3.1%+2.3%+7.5%-4.0%-4.3%+4.7%-1.9%-3.4%+4.9%+7.1%+3.8%-6.5%+4.4%-8.4%+8.2%-2.2%+2.7%-9.0%
YoY Change————+11.9%+8.8%+1.0%+3.4%-5.6%-5.0%+4.1%+6.6%+12.8%+9.1%+8.6%-7.1%-3.2%+1.2%-0.4%-1.1%
Range$7.30B – $8.80B
CAGR+1.1%
Avg YoY Growth+2.8%
Median YoY Growth+2.3%

Frequently Asked Questions

What is Bristol-Myers Squibb's united states — total revenues?
Bristol-Myers Squibb (BMY) reported united states — total revenues of $7.79B in Q1 2026.
How has Bristol-Myers Squibb's united states — total revenues changed year-over-year?
Bristol-Myers Squibb's united states — total revenues decreased by 1.1% year-over-year, from $7.87B to $7.79B.
What is the long-term trend for Bristol-Myers Squibb's united states — total revenues?
Over 4 years (2021 to 2025), Bristol-Myers Squibb's united states — total revenues has grown at a 3.3% compound annual growth rate (CAGR), from $29.21B to $33.28B.